Innovative MedTech Files 8-K/A Amendment

TL;DR

IMTH filed an amendment to an 8-K regarding equity sales. Check for updates.

AI Summary

Innovative MedTech, Inc. filed an amendment (8-K/A) on January 8, 2025, to a previous filing concerning unregistered sales of equity securities and Regulation FD disclosure, with the earliest event reported on December 17, 2024. The company, formerly known as Fresh Harvest Products, Inc., is incorporated in Delaware and headquartered in Blue Island, IL.

Why It Matters

This filing is an amendment to a previous report, indicating a correction or addition to information regarding unregistered equity sales or disclosures, which could impact investor understanding of the company's capital structure and communications.

Risk Assessment

Risk Level: low — This is an amendment to a previous filing, not a new event, and the details provided are procedural rather than indicating significant new risks.

Key Players & Entities

• Innovative MedTech, Inc. (company) — Registrant
• Fresh Harvest Products, Inc. (company) — Former company name
• December 17, 2024 (date) — Earliest event reported date
• January 8, 2025 (date) — Filing date of amendment

FAQ

Key Financial Figures

• $325,000 — satisfaction of accrued compensation of $325,000 owed to Mr. Friedman and his entity by
• $23.15 billion — d care market size was estimated at USD $23.15 billion in 2024 and is projected to grow at a C
• $7.98 billion — is treatments is estimated to be around $7.98 billion (Business Research Insights, https://ww
• $9.98 billion — s, and market is projected to touch USD $9.98 billion by 2032 at CAGR 2.5% during the forecas

Filing Documents

• imth_8ka.htm (8-K/A) — 36KB
• 0001477932-25-000114.txt ( ) — 151KB
• imth-20241217.xsd (EX-101.SCH) — 6KB
• imth-20241217_lab.xml (EX-101.LAB) — 13KB
• imth-20241217_cal.xml (EX-101.CAL) — 1KB
• imth-20241217_pre.xml (EX-101.PRE) — 8KB
• imth-20241217_def.xml (EX-101.DEF) — 2KB
• imth_8ka_htm.xml (XML) — 3KB

02. Unregistered Sales of Equity Securities

Item 3.02. Unregistered Sales of Equity Securities. On December 17, 2024, Innovative MedTech, Inc. (the " Company " or " IMTH ") issued 6,500,000 shares of common stock to Red Halo, LLC, the limited liability company of Company CEO Michael Friedman, in satisfaction of accrued compensation of $325,000 owed to Mr. Friedman and his entity by the Company. The shares were issued in reliance on the exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Rule 506(b) promulgated thereunder, as there was no general solicitation, and the transaction did not involve a public offering.

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. The Company furnishes the following business updates to its shareholders: IMTH Plans to Enter Advanced Wound Care Market o IMTH has recently signed consulting agreements with two highly experienced wound care specialists to manage the Company's expansion into the burgeoning advanced wound care market. IMTH plans to provide advanced wound care services to its 25-unit Sarah Care subsidiary and aggressively pursue many major wound care opportunities outside of the Sarah Care system. IMTH expects to utilize the biological amnionic membrane allograft which has proven to be a dramatic leap forward in wound care for closing and healing infected wounds, beyond anything that has previously been achieved. o IMTH's new consultants have contracts with two of the largest distributors for biological amnion membrane allografts. Their primary objectives are to pursue potential wound care acquisitions and partnerships for IMTH and to make IMTH an active sales representative to the largest consumers of wound care services, including wound care centers, nursing homes, assisted living centers, podiatrists, etc. IMTH is committed to becoming a major player in advanced wound care treatment. o The global wound care market size was estimated at USD $23.15 billion in 2024 and is projected to grow at a CAGR of 4.19% from 2025 to 2030 (https://www.grandviewresearch.com/industry-analysis/wound-care-market). IMTH Signs Asset Purchase Agreement with AI Health Technologies o On January 5, 2025, IMTH signed an Asset Purchase Agreement (" APA ") with AI Health Technologies, Inc. to acquire its newly developed CyberHealthAI system. This cutting-edge technology is designed to create an all-in-one universe for healthcare providers that includes refresher training, real time measurements, and video documentation of the entire procedure. CyberHealthAI was originally developed for wound care procedures but has been found to bring added value to man

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INNOVATIVE MEDTECH, INC. Dated: January 8, 2025 By: /s/ Michael Friedman Michael Friedman Chief Executive Officer 4

View Full Filing

View this 8-K/A filing on SEC EDGAR